Discount Drug Store

Discount Drug Store
HomeAlpha IndexCategories

Discount Drugs A

Discount Drugs B

Discount Drugs C

Discount Drugs D

Discount Drugs E

Discount Drugs F

Discount Drugs G

Discount Drugs H

Discount Drugs I

Discount Drugs J

Discount Drugs K

Discount Drugs L

Discount Drugs M

Discount Drugs N

Discount Drugs O

Discount Drugs P

Discount Drugs Q

Discount Drugs R

Discount Drugs S

Discount Drugs T

Discount Drugs U

Discount Drugs V

Discount Drugs W

Discount Drugs X

Discount Drugs Y

Discount Drugs Z

Discount Drugs 0-9

Home

Product Index

Category List

Lithicarb Eskalith

Home » Prescription Drugs 10 » Lithicarb Eskalith

Indications1.Treatment of mania and hypomania. 2.Lithium may also be tried in the treatment of some patients with recurrent bipolar depression for which treatment with other antidepressants has been unsuccessful. 3.Prophylactic treatment of recurrent affective disorders.Dosage and AdministrationA simple treatment schedule has been evolved which except for some minor variations should be followed whether using LITHICARB FC therapeutically or prophylactically. The minor variations to this schedule depend on the elements of the illness being treated and these are described later.1. In patients of average weight (70kg) an initial dose of 400- 1 200mg of LITHICARB FC may be given as a single daily dose in the morning or on retiring. Alternatively the dose may be divided and given morning and evening. The tablets should not be crushed chewed or swallowed with hot liquids. When changing from other lithium preparations serum lithium levels should first be checked then 2. LITHICARB FC therapy commenced at a daily dose as close as possible to the dose of the other form of lithium. As bioavailability varies from product to product (particularly with regard to retard or slow release preparations) a change of product should be regarded as initiation of new treatment. 3. Four to five days after starting treatment (and never longer than one week) a blood sample should be taken for the estimation of serum lithium level. 4. The objective is to adjust the LITHICARB FC dose so as to maintain the serum lithium level permanently within the diurnal range of 0.5 - 1.5 mmol/L. In practice the blood sample should be taken between 12 and 24 hours after the previous dose of LITHICARB FC. 'Target' serum lithium concentrations at 12 and 24 hours are shown in Table 1.LITHICARB FC tablets are scored therefore they can be divided accurately to provide dosage adjustments as small as 125mg. Serum lithium levels should be monitored weekly until stabilisation is achieved.Table 1. Target serum lithium concentrations "Target" serum lithium concentration (mmol/L) At 12 hours At 24 hours Once daily dosage 0.7 - 1.0 0.5 - 0.8 Twice daily dosage 0.5 - 0.8 4. Lithium therapy should not be initiated unless adequate facilities for routine monitoring of serum concentrations are available. Following stabilisation of serum lithium levels the period between subsequent estimations can be increased gradually but should not normally exceed three months. Additional measurements should be made following alteration of dosage on development of intercurrent disease signs of manic or depressive relapse following significant change in sodium or fluid intake or if signs of lithium toxicity occur. 5. Whilst a high proportion of acutely ill patients may respond within three to seven days of the commencement of LITHICARB FC therapy LITHICARB FC should be continued through any recurrence of the affective disturbance. This is important as the full prophylactic effect may not occur for 6 to 12 months after the initiation of therapy. 6. In patients who show a positive response to LITHICARB FC therapy treatment is likely to be long term. Careful clinical appraisal of the patient should be exercised throughout medication (see Precautions).Treatment of Acute Mania Hypomania and Recurrent Bipolar Depression:It is likely that a higher than normal LITHICARB FC intake may be necessary during an acute phase and divided doses would be required here. Therefore as soon as control of mania or depression is achieved the serum lithium level should be determined and it may be necessary dependent on the results to lower the dose of LITHICARB FC and re-stabilise serum lithium levels. In all other details the described treatment schedule is recommended.Prophylactic Treatment of Recurrent Affective DisordersIt is recommended that the described treatment schedule is followed.Use in the Elderly:In elderly patients or those below 50kg in weight it is recommended that the starting dose be 400mg. Elderly patients may be more sensitive to undesirable effects of lithium and may also require lower doses in order to maintain normal serum lithium levels. It follows therefore that long term patients often require a reduction in dosage over a period of years.Use in Children and AdolescentsNot recommended.

Buy Lithicarb Eskalith and other Prescription Drugs 10 products online at Medstore.

Buy Online at Medstore - Click Here!

About Lithicarb Eskalith:

Product Type: Prescription Drugs 10

Lithicarb ( Eskalith Generic Lithium Carbonate )

Lithicarb (Eskalith Generic Lithium Carbonate)

Eskalith Generic Lithium Carbonate

250mg Eskalith Generic Lithium Carbonate Lithicarb

View more Prescription Drugs 10

Previous Product  Next Product

Discount Drug Store: What Medstore Says about their Cheap Drug Store : Catalogue review of prescription medications - Our online pharmacy offers to its customers a wide range of prescription drugs for anxiety, erectile dysfunction, weight loss, pain medicines. Popular prescription drugs like anti depressants are available with us at no prescription and are quite cheap. You can also buy discount prescription antibiotics and many other prescription drugs. Company profile - Our company is specialized in supplying prescription drugs. No prescription needed. Customers just have to go through an online consultation process. Full prescription information is available on our online store. We have a large customer base worldwide offering discount prescription drugs. Advantages of buying prescription drugs online. Internet is rapidly transforming the way we live, work and shop in all sectors of the economy. In the health sector, internet permits individuals to obtain extensive medical information, to help them understand health issues and treatment options. Millions of people all around the world used internet year to find medical information. The sale of most consumer products over internet has grown rapidly in recent years, including the sale of prescriptions drugs. Purchasing prescription drugs online can provide tremendous benefits to consumers. These benefits are many and include: •Access to prescription drugs for the disabled or otherwise homebound, for whom a trip to the pharmacy can be difficult; •The convenience of shopping 24 hours a day; •Wide selection of prescription drugs; •Privacy for those who do not want to discuss their medical needs in a public place; •Lower costs, as well as convenience, if the purchase is made from a reputable site. FDA is aware that many reputable internet pharmacies provide consumers seeking prescription drugs with a measure of safety, privacy and convenience. They can provide detailed information on drug interactions, and may e-mail customers if the drug they ordered has been recalled, a cheaper generic version of the drug becomes available or to remind them on prescription renewals. Hyperlinks and search programs provide online customers with written product information and references to other sources of health information more easily than traditional stores. Finally, consumers must have confidence that safeguards for online customers are at least as protective as those at traditional pharmacies.
 
Drug News - A simple function that most of us take for granted - swallowing - is the focus of University of Adelaide research which could help thousands of stroke sufferers around the world. In an Australian first, researchers from the University's Robinson Institute are using magnetic stimulators to jump start the brain after a stroke and repair swallowing functions which break down in more than 50% of stroke patients. Speech pathologist Dr Sebastian Doeltgen, who is part of the University's Neuromotor Plasticity & Development Research Group, has been awarded $300,000 in Federal Government funding to investigate revolutionary techniques to treat swallowing disorders. "About 60,000 people suffer strokes each year in Australia alone, with more than 35,000 of these initially experiencing problems with swallowing. That is a huge part of the stroke population who have difficulty eating or drinking and may have to be fed through a tube," he says.
 
Xalatan Generic Latanoprost 
Xalatan (Latanoprost) 
Xatral Uroxatral 
XELODA Generic Capecitabine 
orlistat Generic Orlistat 
orlistat (Orlistat) 
Xergic Telfast 
XET Seroxat 
X worm Albenza 
Xylocaine Jelly Generic Lignocaine 
Xylocaine Generic Lidocaine 
XYLOCAINE Pump Spray Generic Lidocaine 
Xyzal Generic Levocetririzine